反应 #1797516

ord-a45fa349eb6944c2b13435c6cf4cffdd

反应方程式

COC(=O)c1ccc(N2CCN(c3ccc(C(C)(C)C)cc3)C2=O)cc1
methyl 4-(3-(4-tert-butylphenyl)-2-oxoimidazolidin-1-yl)benzoate
CC(C)[CH2][AlH][CH2]C(C)C
DIBAL
CC(C)(C)c1ccc(N2CCN(c3ccc(CO)cc3)C2=O)cc1
1-(4-tert-Butylphenyl)-3-(4-(hydroxymethyl)phenyl)imidazolidin-2-one

反应条件

详细条件
See reaction.notes.procedure_details.

后处理

  1. 1
    其他quenched with ml of sat's Rochelle salt solution
  2. 2
    其他The mixture was partitioned between 100 ml dichloromethane and 50 ml of 1 N NaOH
  3. 3
    其他The organic layer was separated
  4. 4
    其他dried
  5. 5
    浓缩concentrated
  6. 6
    其他The residue was purified on ISCO system (5% methanol in dichloromethane)
  7. 7
    其他to give a pure product as a white crystalline (113 mg, 35%)

实验过程

A solution of methyl 4-(3-(4-tert-butylphenyl)-2-oxoimidazolidin-1-yl)benzoate (270 mg, 0.77 mmol) in dichloromethane (50 ml) at −78° C. was treated with ml of 1.0 M DIBAL solution in dichloromethane. The resulting solution was stirred cold for 2 hour, then quenched with ml of sat's Rochelle salt solution. The mixture was partitioned between 100 ml dichloromethane and 50 ml of 1 N NaOH. The organic layer was separated, dried and concentrated. The residue was purified on ISCO system (5% methanol in dichloromethane) to give a pure product as a white crystalline (113 mg, 35%): 1H NMR (400 MHz, CDCl3) δ 7.60 (d, 2H), 7.50 (d, 2H), 7.10 (m, 4H), 4.64 (s, 2H), 4.00 (s, 4H), 1.58 (s, 9H).

来源

DOI: 10.6084/m9.figshare.5104873.v1专利: US07790707B2uspto-grants-2010_09